Perioperative CapeOx therapy for advanced gastric cancer with extensive lymph node metastasis (OGSG1701)

ASTRON (OGSG 2401): A multicenter prospective trial of ferric carboxymaltose without erythropoiesis-stimulating agents for iron deficiency anemia in patients with gastric/colorectal cancer receiving chemotherapy

A Multicenter Phase II Trial of Encorafenib, Binimetinib and Cetuximab for Early Relapsed Stage II/III BRAFV600E-mutated Colorectal Cancer: TRESBIEN trial (OGSG 2101)

Characteristics of conversion surgery cases for gastric cancer-Multicenter retrospective cohort study (OGSG2301)-

高度リンパ節転移を伴う進行胃癌に対する周術期Capecitabine＋Oxaliplatin (CapeOx)療法第II相試験(OGSG1701) ：3年間の追跡結果

Long-term Outcomes of Perioperative CapeOx for Advanced Gastric Cancer with Extensive Lymph Node Metastasis (OGSG1701)

Efficacy and Safety of Irinotecan-based therapy in Elderly Patients with Advanced Gastric Cancer: Subgroup Analysis of the RINDBeRG Trial

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402)

Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701

大型3型/4型胃癌に対する術前S-1＋CDDP＋DTX併用療法による第II相試験（OGSG 1402）：5年長期成績